Ali Asifinsider trades
In SEC Form 4 filings, Ali Asif is listed as Chief Financial Officer of Protagonist Therapeutics, Inc (PTGX). In the last 90 days, Ali Asif sold $8.31M of Protagonist Therapeutics, Inc (PTGX) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | Chief Financial Officer | 10 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M | 9,229 | $38.98 | $359,746 | 68,232 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M | 28,438 | $23.42 | $666,018 | 96,670 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M | 15,650 | $19.19 | $300,324 | 112,320 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M | 5,312 | $12.17 | $64,647 | 117,632 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | S | 12,595 | $141.77 | Sale −$1,785,593 | 105,037 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | S | 46,034 | $141.78 | Sale −$6,526,701 | 59,003 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M · derivative | 9,229 | $38.98 | $359,746 | 29,291 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M · derivative | 28,438 | $23.42 | $666,018 | 49,562 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M · derivative | 15,650 | $19.19 | $300,324 | 51,150 | Yes | Form 4 |
| PTGXProtagonist Therapeutics, Inc | Sep 30 | Oct 2 | M · derivative | 5,312 | $12.17 | $64,647 | 25,235 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.